Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Isaacson

Showing results (51-60 of 65) with videos related to

Pageof 7
Sort By:
The Journal of Antimicrobial Chemotherapy|February 1, 1990
In-vivo evaluation of ofloxacin in Salmonella typhimurium infection in miceK P Fu, J Hilliard, D Isaacson, et al.
IEEE Transactions on Bio-Medical Engineering|August 1, 1994
ACT3: a high-speed, high-precision electrical impedance tomographR D Cook, G J Saulnier, D G Gisser, et al.
Physiological Measurement|May 27, 2015
Estimating a regional ventilation-perfusion indexP A Muller, T Li, D Isaacson, et al.
Current Drug Safety|June 19, 2009
Clinical observation of liver chemistry abnormalities in asthmaticsDavid A Katz, Jeffrey D Isaacson, Lixin Han, et al.
Physiological Measurement|November 14, 2022
Fast absolute 3D CGO-based electrical impedance tomography on experimental tank dataS J Hamilton, P A Muller, D Isaacson, et al.
AIDS (London, England)|October 30, 2003
Lack of correlation between SREBF1 genotype and hyperlipidemia in individuals treated with highly active antiretroviral therapyAiming Yang, Martin S King, Lixin Han, et al.
Antiviral Therapy|December 19, 2002
Analysis of the virological response with respect to baseline viral phenotype and genotype in protease inhibitor-experienced HIV-1-infected patients receiving lopinavir/ritonavir therapyDale J Kempf, Jeffrey D Isaacson, Martin S King, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 13, 2003
Phase I dose-escalation study of the safety and pharmacokinetics of atrasentan: an endothelin receptor antagonist for refractory prostate cancerBernard A Zonnenberg, Gerard Groenewegen, Todd J Janus, et al.
Elife|November 18, 2020
Spatial readout of visual looming in the central brain of <i>Drosophila</i>Mai M Morimoto, Aljoscha Nern, Arthur Zhao, et al.
Cancer|September 22, 2007
A phase 3 randomized controlled trial of the efficacy and safety of atrasentan in men with metastatic hormone-refractory prostate cancerMichael A Carducci, Fred Saad, Per-Anders Abrahamsson, et al.
Pageof 7

Showing results (51-60 of 65) with videos related to

Sort By:
Pageof 7
The Journal of Antimicrobial Chemotherapy|February 1, 1990
In-vivo evaluation of ofloxacin in Salmonella typhimurium infection in miceK P Fu, J Hilliard, D Isaacson, et al.
IEEE Transactions on Bio-Medical Engineering|August 1, 1994
ACT3: a high-speed, high-precision electrical impedance tomographR D Cook, G J Saulnier, D G Gisser, et al.
Physiological Measurement|May 27, 2015
Estimating a regional ventilation-perfusion indexP A Muller, T Li, D Isaacson, et al.
Current Drug Safety|June 19, 2009
Clinical observation of liver chemistry abnormalities in asthmaticsDavid A Katz, Jeffrey D Isaacson, Lixin Han, et al.
Physiological Measurement|November 14, 2022
Fast absolute 3D CGO-based electrical impedance tomography on experimental tank dataS J Hamilton, P A Muller, D Isaacson, et al.
AIDS (London, England)|October 30, 2003
Lack of correlation between SREBF1 genotype and hyperlipidemia in individuals treated with highly active antiretroviral therapyAiming Yang, Martin S King, Lixin Han, et al.
Antiviral Therapy|December 19, 2002
Analysis of the virological response with respect to baseline viral phenotype and genotype in protease inhibitor-experienced HIV-1-infected patients receiving lopinavir/ritonavir therapyDale J Kempf, Jeffrey D Isaacson, Martin S King, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 13, 2003
Phase I dose-escalation study of the safety and pharmacokinetics of atrasentan: an endothelin receptor antagonist for refractory prostate cancerBernard A Zonnenberg, Gerard Groenewegen, Todd J Janus, et al.
Elife|November 18, 2020
Spatial readout of visual looming in the central brain of <i>Drosophila</i>Mai M Morimoto, Aljoscha Nern, Arthur Zhao, et al.
Cancer|September 22, 2007
A phase 3 randomized controlled trial of the efficacy and safety of atrasentan in men with metastatic hormone-refractory prostate cancerMichael A Carducci, Fred Saad, Per-Anders Abrahamsson, et al.
Pageof 7